Literature DB >> 18842060

Assay for glucosamine 6-phosphate using a ligand-activated ribozyme with fluorescence resonance energy transfer or CE-laser-induced fluorescence detection.

Jennifer R W Furchak1, Peilin Yang, Colin Jennings, Nils G Walter, Robert T Kennedy.   

Abstract

A naturally occurring aptazyme, the glmS ribozyme, is adapted to an assay for glucosamine 6-phosphate, an effector molecule for the aptazyme. In the assay, binding of analyte allosterically activates aptazyme to cleave a fluorescently labeled oligonucleotide substrate. The extent of reaction, and hence analyte concentration, is detected by either fluorescence resonance energy transfer (FRET) or capillary electrophoresis with laser-induced fluorescence (CE-LIF). With FRET, assay signal is the rate of increase in FRET in presence of analyte. With CE-LIF, the assay signal is the peak height of cleavage product formed after a fixed incubation time. The assay has a linear response up to 100 (CE-LIF) or 500 microM (FRET) and detection limit of approximately 500 nM for glucosamine 6-phosphate under single-turnover conditions. When substrate is present in excess of the aptazyme, it is possible to amplify the signal by multiple turnovers to achieve a 13-fold improvement in sensitivity and detection limit of 50 nM. Successful signal amplification requires a temperature cycle to alternately dissociate cleaved substrate and allow fresh substrate to bind aptazyme. The results show that aptazymes have potential utility as analytical reagents for quantification of effector molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842060      PMCID: PMC2597777          DOI: 10.1021/ac801410k

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  42 in total

1.  Cooperative binding of effectors by an allosteric ribozyme.

Authors:  A M Jose; G A Soukup; R R Breaker
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  Design and optimization of effector-activated ribozyme ligases.

Authors:  M P Robertson; A D Ellington
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

3.  Altering molecular recognition of RNA aptamers by allosteric selection.

Authors:  G A Soukup; G A Emilsson; R R Breaker
Journal:  J Mol Biol       Date:  2000-05-12       Impact factor: 5.469

4.  Rapid simultaneous determination of glucagon and insulin by capillary electrophoresis immunoassays.

Authors:  I German; R T Kennedy
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-06-09

5.  Detection of small organic analytes by fluorescing molecular switches.

Authors:  C Frauendorf; A Jäschke
Journal:  Bioorg Med Chem       Date:  2001-10       Impact factor: 3.641

6.  Engineering high-speed allosteric hammerhead ribozymes.

Authors:  Kristian H Link; Lixia Guo; Tyler D Ames; Laising Yen; Richard C Mulligan; Ronald R Breaker
Journal:  Biol Chem       Date:  2007-08       Impact factor: 3.915

7.  Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.

Authors:  Y Komatsu; S Yamashita; N Kazama; K Nobuoka; E Ohtsuka
Journal:  J Mol Biol       Date:  2000-06-23       Impact factor: 5.469

8.  Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP.

Authors:  M Koizumi; G A Soukup; J N Kerr; R R Breaker
Journal:  Nat Struct Biol       Date:  1999-11

9.  Generating new ligand-binding RNAs by affinity maturation and disintegration of allosteric ribozymes.

Authors:  G A Soukup; E C DeRose; M Koizumi; R R Breaker
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

10.  Immobilized RNA switches for the analysis of complex chemical and biological mixtures.

Authors:  S Seetharaman; M Zivarts; N Sudarsan; R R Breaker
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

View more
  1 in total

1.  An expanded collection and refined consensus model of glmS ribozymes.

Authors:  Phillip J McCown; Adam Roth; Ronald R Breaker
Journal:  RNA       Date:  2011-03-02       Impact factor: 4.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.